Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.66
-0.38 (-6.29%)
May 2, 2025, 4:00 PM EDT - Market closed
Aligos Therapeutics Revenue
In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%. Aligos Therapeutics had revenue of $629.00K in the quarter ending December 31, 2024, a decrease of -76.54%.
Revenue (ttm)
$3.95M
Revenue Growth
-74.60%
P/S Ratio
8.89
Revenue / Employee
$56,357
Employees
70
Market Cap
34.24M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.19B |
Eli Lilly and Company | 49.00B |
Thermo Fisher Scientific | 42.90B |
ALGS News
- 4 days ago - Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025 - GlobeNewsWire
- 10 days ago - Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Presents Positive Data at APASL 2025 - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Announces $105 Million Private Placement Financing - GlobeNewsWire
- 5 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024 - GlobeNewsWire